22217-80-7

Basic information

• Product Name: 5-(4-Methoxy-Phenyl)-3,4-Dihydro-2H-Pyrrole
• Synonyms: 5-(4-Methoxy-Phenyl)-3,4-Dihydro-2H-Pyrrole
• CAS NO: 22217-80-7
• Molecular Formula: C₁₁H₁₃NO
• Molecular Weight: 175.23
• Mol File: 22217-80-7.mol
• Article Data: 24

Chemical Properties

• Boiling Point: 264.6°Cat760mmHg
• Flash Point: 94.7°C
• Appearance: /
• Density: 1.07g/cm³
• Vapor Pressure: 0.016mmHg at 25°C
• Refractive Index: 1.556
• CAS DataBase Reference: 5-(4-Methoxy-Phenyl)-3,4-Dihydro-2H-Pyrrole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-Methoxy-Phenyl)-3,4-Dihydro-2H-Pyrrole(22217-80-7)
• EPA Substance Registry System: 5-(4-Methoxy-Phenyl)-3,4-Dihydro-2H-Pyrrole(22217-80-7)

Safety Data

• Hazardous Substances Data: 22217-80-7(Hazardous Substances Data)

Usage

General Description

The chemical "5-(4-Methoxy-Phenyl)-3,4-Dihydro-2H-Pyrrole" is a unique compound with a complex structure. It contains a pyrrole ring, which is a five-membered aromatic ring with one nitrogen atom. The presence of a 4-Methoxy-Phenyl group further adds to its complexity, making it a potential building block for the synthesis of larger organic molecules. 5-(4-Methoxy-Phenyl)-3,4-Dihydro-2H-Pyrrole has the potential to be used in pharmaceuticals, agrochemicals, and materials science due to its interesting structural features and potential biological activity. Further research and analysis of this chemical could reveal its specific properties and potential applications in various fields.

InChI:InChI=1/C11H13NO/c1-13-10-6-4-9(5-7-10)11-3-2-8-12-11/h4-7H,2-3,8H2,1H3

Upstream product

• 88-12-0 1-ethenyl-2-pyrrolidinone 
• 14774-77-7 p-methoxyphenyllithium 
• 123-75-1 pyrrolidine 
• 696-62-8 para-iodoanisole 
• 7152-03-6 p-methoxyphenyl cyclopropyl ketone 
• 14468-90-7 N-trimethylsilyl-pyrrolidin-2-one 
• 13139-86-1 4-methoxyphenyl magnesium bromide 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 628-20-6 4-Chlorobutyronitrile 
• 100-09-4 4-methoxybenzoic acid 
• 94-30-4 ethyl 4-methoxybenzoate 
• 727418-56-6 3-(4-methoxy-benzoyl)-1-vinyl-pyrrolidin-2-one 
• 164171-80-6 1-(4-methoxyphenyl)cyclobutan-1-ol 
• 583825-27-8 1-(4-azidobutyl)-4-methoxybezene 

Downstream Products

• 108201-12-3 5-(4-Methoxyphenyl)-2,3-diphenyl-1-azabicyclo<3.3.0>oct-2-en-4-on 
• 111399-26-9 1-methyl-2-(4-methoxyphenyl)-1-pyrrolinium trifluoromethanesulfonate 
• 83314-44-7 5-(4-Methoxy-phenyl)-1-methyl-3,4-dihydro-2H-pyrrolium; iodide 
• 4995-12-4 2-(4-methoxyphenyl)-1H-pyrrole 
• 110014-90-9 7a-(4-Methoxy-phenyl)-2-methylene-hexahydro-pyrrolizine 
• 126328-77-6 C₁₅H₁₅⁽²⁾H₄NO 
• 126328-49-2 C₁₅H₁₅⁽²⁾H₄NO 
• 126328-50-5 C₁₆H₁₇⁽²⁾H₄NO₂ 
• 126328-78-7 C₁₆H₁₇⁽²⁾H₄NO₂ 
• 887361-01-5 2-(4-methoxyphenyl)-2-(pentafluoroethyl)pyrrolidine 
• 154777-21-6 (+)-2-(4-OMe-phenyl)-1-pyrrolidine 
• 154777-21-6 (-)-2-(4-OMe-phenyl)-1-pyrrolidine 
• 1262380-91-5 2-(4-methoxyphenyl)-2-(trifluoromethyl)-pyrrolidine 
• 1315512-50-5 C₁₆H₂₃NO₃ 

Relevant articles and documents

Identification of the first structurally validated covalent ligands of the small GTPase RAB27A

Rab27A is a small GTPase, which mediates transport and docking of secretory vesicles at the plasma membrane via protein-protein interactions (PPIs) with effector proteins. Rab27A promotes the growth and invasion of multiple cancer types such as breast, lung and pancreatic, by enhancing secretion of chemokines, metalloproteases and exosomes. The significant role of Rab27A in multiple cancer types and the minor role in adults suggest that Rab27A may be a suitable target to disrupt cancer metastasis. Similar to many GTPases, the flat topology of the Rab27A-effector PPI interface and the high affinity for GTP make it a challenging target for inhibition by small molecules. Reported co-crystal structures show that several effectors of Rab27A interact with the Rab27A SF4 pocket ('WF-binding pocket') via a conserved tryptophan-phenylalanine (WF) dipeptide motif. To obtain structural insight into the ligandability of this pocket, a novel construct was designed fusing Rab27A to part of an effector protein (fRab27A), allowing crystallisation of Rab27A in high throughput. The paradigm of KRas covalent inhibitor development highlights the challenge presented by GTPase proteins as targets. However, taking advantage of two cysteine residues, C123 and C188, that flank the WF pocket and are unique to Rab27A and Rab27B among the >60 Rab family proteins, we used the quantitative Irreversible Tethering (qIT) assay to identify the first covalent ligands for native Rab27A. The binding modes of two hits were elucidated by co-crystallisation with fRab27A, exemplifying a platform for identifying suitable lead fragments for future development of competitive inhibitors of the Rab27A-effector interaction interface, corroborating the use of covalent libraries to tackle challenging targets. This journal is

Intramolecular Cyclization of Brominated Oxime Ether Promoted with Ytterbium(0) to the Synthesis of Cyclic Imines

The first utility of ytterbium(0) as a mediating-metal in the intramolecular cyclization of brominated oxime ether was reported in this paper. In contrast to the prior methods, the N–O bond was used as a receptor of nucleophilic reagent, rather than as a source of N-centered radicals. Cyclic imines were obtained in this one-pot reaction with a broad scope of substrates and feasible reaction conditions.

Intramolecular Csp3-H/C-C bond amination of alkyl azides for the selective synthesis of cyclic imines and tertiary amines

The intramolecular Csp3-H and/or C-C bond amination is very important in modern organic synthesis due to its efficiency in the construction of diversified N-heterocycles. Herein, we report a novel intramolecular cyclization of alkyl azides for the synthesis of cyclic imines and tertiary amines through selective Csp3-H and/or C-C bond cleavage. Two C-N single bonds or a CN double bond are efficiently constructed in these transformations. The carbocation mechanism differs from the reported metal nitrene intermediates and therefore enables metal-free and new transformation.